United Community Banks, Inc. UCB

GREENVILLE, S.C., Sept. 30, 2026 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) announces it will release its third quarter 2026 financial results on Tuesday, October 20, 2026, before the stock market opens. The company will hold a conference call at 8:30 a.m. ET on Tuesday, October 20, 2026, to discuss its financial results, business highlights, and outlook. Participants can pre-register for the conference call by navigating to https://dpregister.com/sreg/10209322/1040c6adc70. Tho

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at United Community Banks (NYSE:UCB) and its peers.

The United Community Bank Foundation is marking its fifth anniversary by sharing the impact it's made to build stronger communities throughout the Southeast. To date, the Foundation has awarded $2.96 million through 1,146 grants across Alabama, Florida, Georgia, North Carolina, South Carolina and Tennessee.

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, will present a breadth of data from its innovative myasthenia gravis portfolio at the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Congress Annual Meeting and the Myasthenia Gravis Foundation of America (MGFA) Scientific Session in Orlando, Florida, September 29 to October 2, 2026. Abstracts at AANEM and MGFA will highlight real-world and clinical data demonstrating UCB's targeted treatment portfolio

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

08:00 (EST) – UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to CIMZIA® (certolizumab pegol) for the prevention of placenta-mediated adverse pregnancy outcomes in pregnant women who have antiphospholipid syndrome (APS) and are positive for lupus anticoagulant (LA). These patients were considered at risk due to prior obstetric and blood clotting (thrombotic) events.1

Strategic actions reduce interest rate risk, provide greater liquidity for organic growth, improve balance sheet flexibility, and enhance overall earnings profileGREENVILLE, S.C., Sept. 08, 2026 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (“United” or the “Company”) today announced that, following the September 1 completion of the sale of Navitas Credit Corp. and NLFC Reinsurance Corp (collectively, “Navitas”), which netted the Company approximately $2.0 billion in proceeds, it

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

GREENVILLE, S.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (“United”) today announced the completion of the previously announced sale of its equipment finance business, consisting of Navitas Credit Corp. and NLFC Reinsurance Corp. (collectively, “Navitas”), to funds managed by Wafra Inc., acting through Navitas TopCo LLC (“Wafra”) for approximately $2.0 billion in cash1 (the “Transaction”). The Transaction represents an attractive monetization of the equipment

UCB, a global biopharmaceutical company focused on improving the lives of people living with severe diseases, today announced that they've come to an agreement with the U.S. government that will continue to support patient access to important medicines while enabling significant investment in the research, development, and manufacturing of medicines for people living with severe neurological and immunological diseases.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does United Community Banks (UCB) have what it takes? Let's find out.

United Community Banks (UCB) has drawn fresh attention after appointing Jeff Beisler-Snell to lead its new International Banking and Capital Markets team, a move that broadens the bank’s services for globally active clients. Against this backdrop of leadership changes and a dividend increase, United Community Banks’ share price has eased 3.9% over the past week but is still up 5.4% over 90 days and 11.6% year to date, while the 3 year total shareholder return is 42.0%. Scan other banks that...

United Community has named Jeff Beisler-Snell head of International Banking and Capital Markets, expanding the bank's ability to help customers conduct business around the world.

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.

United Community (NYSE: UCB) today announced that Tom Speir has been named executive vice president and chief financial officer.